MPS Pharmaa Limited Stock

Equities

ADVIKLA

INE537C01019

Market Closed - Bombay S.E. 06:00:56 2024-05-21 am EDT 5-day change 1st Jan Change
3.33 INR 0.00% Intraday chart for MPS Pharmaa Limited 0.00% +19.35%
Sales 2022 324K 3.89K Sales 2023 233K 2.8K Capitalization 40.13M 482K
Net income 2022 -1M -12.01K Net income 2023 -10M -120K EV / Sales 2022 261 x
Net Debt 2022 57.94M 696K Net Debt 2023 67.57M 812K EV / Sales 2023 462 x
P/E ratio 2022
-18.8 x
P/E ratio 2023
-3.82 x
Employees 18
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
MPS Pharmaa Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
MPS Pharmaa Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
MPS Pharmaa Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
MPS Pharmaa Limited Announces Resignation of Manoj Kumar Jain from the Position of the Independent Director of the Company with Immediate Effect CI
MPS Pharmaa Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
MPS Pharmaa Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Advik Laboratories Changes Company Name MT
ADVIK LABORATORIES LIMITED has Changed its Name to MPS PHARMAA LIMITED CI
Advik Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Pataliputra International Ltd acquired a 17.51% stake in Advik Laboratories Limited from Vikas Lifecare Limited for INR 6.09 million. CI
Advik Laboratories Changes Name MT
Advik Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Advik Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Advik Laboratories Limited announced that it expects to receive INR 62.5 million in funding from Neelabh Spinning Mills Pvt. Ltd., Omkam Securities Private Limited, Dhiru Builders and Promoters Private Limited and other investors CI
Advik Laboratories Narrows Net Loss in Fiscal Q3; Shares Jump 5% MT
More news
Current month+4.72%
1 month+3.74%
3 months+8.82%
6 months+19.35%
Current year+19.35%
More quotes
1 week
3.33
Extreme 3.33
3.33
1 month
3.05
Extreme 3.05
3.33
Current year
2.92
Extreme 2.92
3.33
1 year
2.20
Extreme 2.2
3.33
3 years
1.01
Extreme 1.01
3.33
5 years
0.32
Extreme 0.32
3.33
10 years
0.32
Extreme 0.32
15.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 13-07-30
Director of Finance/CFO - 14-09-01
Compliance Officer - 15-09-30
Members of the board TitleAgeSince
Chief Executive Officer 60 13-07-30
Director/Board Member 69 17-01-30
Director/Board Member 51 23-07-12
More insiders
Date Price Change Volume
24-05-21 3.33 0.00% 100

Delayed Quote Bombay S.E., May 21, 2024 at 06:00 am EDT

More quotes
  1. Stock Market
  2. Equities
  3. ADVIKLA Stock